PMC:7283670 / 61047-61370 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T220","span":{"begin":291,"end":296},"obj":"Body_part"}],"attributes":[{"id":"A220","pred":"fma_id","subj":"T220","obj":"http://purl.org/sig/ont/fma/fma49184"}],"text":"Comparison of lopinavir/ritonavir or hydroxychloroquine in patients with mild coronavirus disease (COVID‐19) Drug: lopinavir/ritonavir, Drug: hydroxychloroquine sulfate Korea/COVID‐19 150, all, 16 years to 99 years Treatment Experimental: lopinavir/ritonavir 200 mg/100 mg 2 tablets by mouth, every 12 hr for 7–10 days"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T142","span":{"begin":291,"end":296},"obj":"Body_part"}],"attributes":[{"id":"A142","pred":"uberon_id","subj":"T142","obj":"http://purl.obolibrary.org/obo/UBERON_0000165"}],"text":"Comparison of lopinavir/ritonavir or hydroxychloroquine in patients with mild coronavirus disease (COVID‐19) Drug: lopinavir/ritonavir, Drug: hydroxychloroquine sulfate Korea/COVID‐19 150, all, 16 years to 99 years Treatment Experimental: lopinavir/ritonavir 200 mg/100 mg 2 tablets by mouth, every 12 hr for 7–10 days"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T361","span":{"begin":99,"end":107},"obj":"Disease"},{"id":"T362","span":{"begin":177,"end":185},"obj":"Disease"}],"attributes":[{"id":"A361","pred":"mondo_id","subj":"T361","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A362","pred":"mondo_id","subj":"T362","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Comparison of lopinavir/ritonavir or hydroxychloroquine in patients with mild coronavirus disease (COVID‐19) Drug: lopinavir/ritonavir, Drug: hydroxychloroquine sulfate Korea/COVID‐19 150, all, 16 years to 99 years Treatment Experimental: lopinavir/ritonavir 200 mg/100 mg 2 tablets by mouth, every 12 hr for 7–10 days"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T571","span":{"begin":291,"end":296},"obj":"http://www.ebi.ac.uk/efo/EFO_0000825"}],"text":"Comparison of lopinavir/ritonavir or hydroxychloroquine in patients with mild coronavirus disease (COVID‐19) Drug: lopinavir/ritonavir, Drug: hydroxychloroquine sulfate Korea/COVID‐19 150, all, 16 years to 99 years Treatment Experimental: lopinavir/ritonavir 200 mg/100 mg 2 tablets by mouth, every 12 hr for 7–10 days"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T34447","span":{"begin":14,"end":33},"obj":"Chemical"},{"id":"T27940","span":{"begin":14,"end":23},"obj":"Chemical"},{"id":"T20411","span":{"begin":24,"end":33},"obj":"Chemical"},{"id":"T71837","span":{"begin":37,"end":55},"obj":"Chemical"},{"id":"T131","span":{"begin":116,"end":135},"obj":"Chemical"},{"id":"T12779","span":{"begin":116,"end":125},"obj":"Chemical"},{"id":"T42223","span":{"begin":126,"end":135},"obj":"Chemical"},{"id":"T53502","span":{"begin":143,"end":161},"obj":"Chemical"},{"id":"T77554","span":{"begin":162,"end":169},"obj":"Chemical"},{"id":"T82580","span":{"begin":244,"end":263},"obj":"Chemical"},{"id":"T91739","span":{"begin":244,"end":253},"obj":"Chemical"},{"id":"T7801","span":{"begin":254,"end":263},"obj":"Chemical"}],"attributes":[{"id":"A95585","pred":"chebi_id","subj":"T34447","obj":"http://purl.obolibrary.org/obo/CHEBI_145924"},{"id":"A91040","pred":"chebi_id","subj":"T27940","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A55626","pred":"chebi_id","subj":"T20411","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"},{"id":"A94635","pred":"chebi_id","subj":"T71837","obj":"http://purl.obolibrary.org/obo/CHEBI_5801"},{"id":"A45465","pred":"chebi_id","subj":"T131","obj":"http://purl.obolibrary.org/obo/CHEBI_145924"},{"id":"A80783","pred":"chebi_id","subj":"T12779","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A16005","pred":"chebi_id","subj":"T42223","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"},{"id":"A7815","pred":"chebi_id","subj":"T53502","obj":"http://purl.obolibrary.org/obo/CHEBI_5801"},{"id":"A91479","pred":"chebi_id","subj":"T77554","obj":"http://purl.obolibrary.org/obo/CHEBI_16189"},{"id":"A51223","pred":"chebi_id","subj":"T82580","obj":"http://purl.obolibrary.org/obo/CHEBI_145924"},{"id":"A10452","pred":"chebi_id","subj":"T91739","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A58238","pred":"chebi_id","subj":"T7801","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"}],"text":"Comparison of lopinavir/ritonavir or hydroxychloroquine in patients with mild coronavirus disease (COVID‐19) Drug: lopinavir/ritonavir, Drug: hydroxychloroquine sulfate Korea/COVID‐19 150, all, 16 years to 99 years Treatment Experimental: lopinavir/ritonavir 200 mg/100 mg 2 tablets by mouth, every 12 hr for 7–10 days"}

{"project":"LitCovid-sentences","denotations":[{"id":"T633","span":{"begin":0,"end":323},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Comparison of lopinavir/ritonavir or hydroxychloroquine in patients with mild coronavirus disease (COVID‐19) Drug: lopinavir/ritonavir, Drug: hydroxychloroquine sulfate Korea/COVID‐19 150, all, 16 years to 99 years Treatment Experimental: lopinavir/ritonavir 200 mg/100 mg 2 tablets by mouth, every 12 hr for 7–10 days"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1887","span":{"begin":59,"end":67},"obj":"Species"},{"id":"2055","span":{"begin":14,"end":33},"obj":"Chemical"},{"id":"2056","span":{"begin":116,"end":135},"obj":"Chemical"},{"id":"2057","span":{"begin":244,"end":263},"obj":"Chemical"},{"id":"2121","span":{"begin":78,"end":97},"obj":"Disease"},{"id":"2122","span":{"begin":99,"end":107},"obj":"Disease"},{"id":"2123","span":{"begin":177,"end":185},"obj":"Disease"}],"attributes":[{"id":"A1887","pred":"tao:has_database_id","subj":"1887","obj":"Tax:9606"},{"id":"A2055","pred":"tao:has_database_id","subj":"2055","obj":"MESH:C558899"},{"id":"A2056","pred":"tao:has_database_id","subj":"2056","obj":"MESH:C558899"},{"id":"A2057","pred":"tao:has_database_id","subj":"2057","obj":"MESH:C558899"},{"id":"A2121","pred":"tao:has_database_id","subj":"2121","obj":"MESH:D018352"},{"id":"A2122","pred":"tao:has_database_id","subj":"2122","obj":"MESH:C000657245"},{"id":"A2123","pred":"tao:has_database_id","subj":"2123","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Comparison of lopinavir/ritonavir or hydroxychloroquine in patients with mild coronavirus disease (COVID‐19) Drug: lopinavir/ritonavir, Drug: hydroxychloroquine sulfate Korea/COVID‐19 150, all, 16 years to 99 years Treatment Experimental: lopinavir/ritonavir 200 mg/100 mg 2 tablets by mouth, every 12 hr for 7–10 days"}